- Home
- HCWB vs ARBB Comparison
HCWB vs ARBB Comparison
Compare HCWB & ARBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- ARBB
- Stock Information
- Founded
- HCWB 2018
- ARBB 1997
- Country
- HCWB United States
- ARBB Singapore
- Employees
- HCWB N/A
- ARBB N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- ARBB EDP Services
- Sector
- HCWB Health Care
- ARBB Technology
- Exchange
- HCWB Nasdaq
- ARBB Nasdaq
- Market Cap
- HCWB 16.1M
- ARBB 15.9M
- IPO Year
- HCWB 2021
- ARBB 2023
- Fundamental
- Price
- HCWB $6.14
- ARBB $5.95
- Analyst Decision
- HCWB Strong Buy
- ARBB
- Analyst Count
- HCWB 1
- ARBB 0
- Target Price
- HCWB $35.00
- ARBB N/A
- AVG Volume (30 Days)
- HCWB 2.0M
- ARBB 14.3K
- Earning Date
- HCWB 05-15-2025
- ARBB 06-13-2025
- Dividend Yield
- HCWB N/A
- ARBB N/A
- EPS Growth
- HCWB N/A
- ARBB N/A
- EPS
- HCWB N/A
- ARBB N/A
- Revenue
- HCWB $1,445,145.00
- ARBB $24,425,491.00
- Revenue This Year
- HCWB N/A
- ARBB N/A
- Revenue Next Year
- HCWB N/A
- ARBB N/A
- P/E Ratio
- HCWB N/A
- ARBB N/A
- Revenue Growth
- HCWB N/A
- ARBB N/A
- 52 Week Low
- HCWB $5.00
- ARBB $3.22
- 52 Week High
- HCWB $100.80
- ARBB $18.60
- Technical
- Relative Strength Index (RSI)
- HCWB 36.95
- ARBB 28.61
- Support Level
- HCWB $7.55
- ARBB $6.32
- Resistance Level
- HCWB $8.75
- ARBB $9.62
- Average True Range (ATR)
- HCWB 0.85
- ARBB 0.84
- MACD
- HCWB -0.14
- ARBB -0.31
- Stochastic Oscillator
- HCWB 4.60
- ARBB 7.34
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.